39 Recruiting Acute Leukemia Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Acute Leukemia
Related Conditions
Top Recruiting Acute Leukemia Studies
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
📍 Rebecca and John Moores UCSD Cancer Center — La Jolla, California
View Study & Checklist ➔ATG Plus PTCy vs ATG for CGVHD Prophylaxis
📍 Kinghorn Cancer Centre, St Vincent's Health Network — Darlinghurst, New South Wales
View Study & Checklist ➔Cancer Stem Cells in Acute Leukemia
📍 Sanford — Fargo, North Dakota
View Study & Checklist ➔A High Intensity Electronic Health Intervention for the Reduction of Learning Disparities in Childhood Cancer Survivors
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔Prevention of Hospital Acquired Deconditioning in Hospitalized Acute Leukemia Patients
📍 North Shore University Hospital (NSUH) — Manhasset, New York
View Study & Checklist ➔A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies
📍 City of Hope — Duarte, California
View Study & Checklist ➔TBI Using IMRT (VMAT or Tomotherapy) for the Prevention of Pul Toxicities in Patients Undergoing Donor SCT
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
📍 New York Medical College — Valhalla, New York
View Study & Checklist ➔Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta Testing
📍 Dana-Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia
📍 Hartford Healthcare Cancer Institute @ Hartford Hospital — Hartford, Connecticut
View Study & Checklist ➔A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
📍 City of Hope — Duarte, California
View Study & Checklist ➔Biomarkers in Patients With Anemia-Induced Thrombocytopenic Bleeding
📍 Juravinski Hospital — Hamilton, Ontario
View Study & Checklist ➔Umbilical Cord Blood Transplantation From Unrelated Donors
📍 Wilmot Cancer Institute — Rochester, New York
View Study & Checklist ➔A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)
📍 University of Chicago Medicine Comprehensive Cancer Center — Chicago, Illinois
View Study & Checklist ➔Familial Investigations of Childhood Cancer Predisposition
📍 St. Jude Children's Research Hospital — Memphis, Tennessee
View Study & Checklist ➔Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
📍 Masonic Cancer Center at University of Minnesota — Minneapolis, Minnesota
View Study & Checklist ➔Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
View Study & Checklist ➔Trial of 2 Step ATG for Prevention of Acute GVHD Post Allogeneic Stem Cell Transplant
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔Emotion and Symptom-Focused Engagement Trial for Individuals With Acute Leukemia
📍 Juravinski Cancer Centre at Hamilton Health Sciences — Hamilton, Ontario
View Study & Checklist ➔CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT
📍 Children's Hospital of Philadelphia — Philadelphia, Pennsylvania
View Study & Checklist ➔Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation
📍 Lucille Packard Children's Hospital of Stanford University — Palo Alto, California
View Study & Checklist ➔Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔Standard-of-Care Reduced-Intensity Conditioning (RIC) With 200 Versus 400 cGy of Total Body Irradiation (TBI) in Patients With Acute Leukemia Undergoing First Allogeneic Blood or Marrow Transplantation (BMT)
📍 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins — Baltimore, Maryland
View Study & Checklist ➔BMT-06: Study of Intensity Modulated Total Marrow Irradiation (IM-TMI)
📍 University of Illinois Cancer Center — Chicago, Illinois
View Study & Checklist ➔